Abstract
Fetal 1H-MRS is a promising non-invasive technique for assessing metabolic integrity in the developing brain, and has the potential to open a critical presently unavailable window for antenatal cerebral surveillance in the high-risk pregnancy. However, ongoing work is needed to improve the technical success of this emerging technique so as to increase and optimize its utility in the clinical setting. To date in vivo studies have provided important normative data for second and third trimester fetal brain metabolic concentrations in healthy fetuses. Additional studies are needed to elucidate the complex role of these metabolites throughout gestation. This in turn will lay the foundation for the development of clinically meaningful 1H-MRS biomarkers for the accurate assessment of fetal health and well-being. Finally, although a number of studies have performed in vivo spectroscopy studies, the long-term prognostic significance of these acute metabolic findings warrant further study.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heerschap A, van den Berg PP. Proton magnetic resonance spectroscopy of human fetal brain. Am J Obstet Gynecol. 1994;170:1150–1.
Girard N, Confort Gouny S, Viola A, et al. Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy. Magn Reson Med. 2006;56:768–75.
Limperopoulos C, Tworetzky W, McElhinney DB, et al. Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation. 2010;121:26–33.
Heerschap A, Kok RD, van der Berg PP. Antenatal proton MR spectroscopy of the human brain in vivo. Childs Nerv Syst. 2003;19:418–21.
Story L, Damodaram MS, Allsop JM, et al. Proton magnetic resonance spectroscopy in the fetus. Eur J Obstet Gynecol. 2011;158:3–8.
Roelants-van Rijn AM, Groenendaal F, Stoutenbeek P, van der Grond J. Lactate in the foetal brain: detection and implications. Acta Paediatr. 2004;93:937–40.
Kreis R, Ernst T, Ross BD. Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med. 1993;30:424–37.
Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Huppi PS. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2002;48:949–58.
Limperopoulos C. Disorders of the fetal circulation and the fetal brain. Clin Perinatol. 2009;36:561–77.
Kok RD, van den Berg PP, van den Bergh AJ, Nijland R, Heerschap A. Maturation of the human fetal brain as observed by 1H MR spectroscopy. Magn Reson Med. 2002;48:611–6.
Urenjak J, Willliams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem. 1992;59:55–61.
Huppi PS, Fusch C, Boesch C, et al. Regional metabolic assessment of human brain during development by proton magnetic resonance spectroscopy in vivo and by high-performance liquid chromatography/gas chromatography in autopsy tissue. Pediatr Res. 1995;37:145–50.
Roelants-van Rijn AM, van der Grond J, Stigter RH, de Vries LS, Groenendaal F. Cerebral structure and metabolism and long-term outcome in small-for-gestational-age preterm neonates. Pediatr Res. 2004;56:285–90.
Fenton BW, Lin CS, Macedonia C, Schellinger D, Ascher S. The fetus at term: In utero volume-selected proton MR spectroscopy with a breath-hold technique- A feasibility study. Radiology. 2001;219:563–6.
Cady E, Penrice J, Arness P, et al. Lactate, N-acetyl-aspartate, choline and creatine concentrations and spin-spin relaxation in thalamic and occipito-parietal regions of developing human brain. Magn Reson Med. 1996;36:878–86.
Huppi PS, Warfield S, Kikinis R, et al. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Am Neurol. 1998;43:224–35.
Bhakoo KK, Pearce D. In vitro expression of N-acetyl-aspartate by oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem. 2000;74:254–62.
Kreis R, Ernst T, Ross B. Absolute quantification of water and metabolites in the human brain. Part II. Metabolite concentrations. J Magn Reson. 1993;103:9–19.
Fisher SK, Novak JE, Agranoff BW. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem. 2002;82:736–54.
Beemster P, Groenen P, Steegers-Theunissen RPM. The involvement of inositol in reproduction. Nutr Rev. 2002;60:80–8.
Kato N. Dependence of long-term depression of postsynaptic metabotropic glutamate receptors in visual cortex. Proc Natl Acad Sci USA. 1993;90:3650–4.
Novak JE, Turner RS, Agranoff BW, Fisher SK. Differentiated human NT2-N neurons possess a high intracellular content of myo-inositol. J Neurochem. 1999;72:1431–40.
Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec. 2001;265:54–84.
Fisher SK, Novak JE, Agranoff BW. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem. 2002;82:736–54.
Greene ND, Copp AJ. Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med. 1997;3:60–6.
Brighina E, Bresolin N, Pardi G, Rango M. Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy. Pediatr Neurol. 2008;40(5):327–42.
Barker P, Breiter S, Soher B, et al. Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations. Magn Reson Med. 1994;32:157–63.
Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography study of human brain functional development. Ann Neurol. 1987;22:487–97.
Stockler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res. 1994;36:409–13.
Bizzi A, Bugiani M, Salomons GS, et al. X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8. Ann Neurol. 2002;52:227–31.
Rutherford JM, Moody A, Crawshaw S, Rubin PC. Magnetic resonance spectroscopy in pre-eclampsia: evidence of cerebral ischaemia. Br J Obstet Gynaecol. 2003;110:416–23.
Fisher MC, Zeisel SH, Mar MH, Sadler TW. Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. FASEB J. 2002;16:619–21.
Zeisel SH, Niculescu MD. Perinatal choline influences brain structure and function. Nutr Rev. 2004;64:197–203.
Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13:981–9.
Jacobs MA, Horska A, van Zijil PC, Barker PB. Quantitative proton MR spectroscopic imaging of normal human cerebellum and brainstem. Magn Reson Med. 2001;46:699–705.
Magistretti FG, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science. 1999;283:496–7.
Hutternlocher PR, de Courten C, Garey LJ, Van der Loos H. Synaptogenesis in human visual cortex-evidence for synapse elimination during normal development. Neurosci Lett. 1982;33:247–52.
Gallo V, Ghiani CA. Glutamate receptors in glia: new cells, new inputs and new functions. Trends Pharmacol Sci. 2000;21:252–8.
Gallo V, Zhou JM, McBain CJ, Wright PW, Knutson PL, Amstrong RC. Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J Neurosci. 1996;16:2659–70.
Yuan X, Eisen AM, McBain CJ, Gallo V. A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development. 1998;125:2901–14.
Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extra-cellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;4:1369–74.
Hagberg H. Hypoxic-ischemic damage in the neonatal brain: excitatory amino acids. Dev Pharmacol Ther. 2002;18:139–44.
Follet P, Deng W, Dai W, et al. Topiramate protection in immature brain injury. J Neurosci. 2004;24:4412–20.
Volpe JJ. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics. 2005;116:221–5.
Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet. 2009;8:110–24.
Itoh T, Beesley J, Itoh A, et al. AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem. 2002;81:390–402.
Rosenberg PA, Dai W, Gan X, et al. Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res. 2003;71:237–45.
Girard N, Fogliarini C, Viola A, et al. MRS of normal and impaired fetal brain development. Eur J Radiol. 2006;57:217–25.
Vannucci RC, Vannucci SJ. Glucose metabolism in the developing brain. Semin Perinatol. 2000;24:107–15.
Khalan S, Parimi P. Gluconeogenesis in the fetus and neonate. Semin Perinatol. 2000;24:94–106.
Zarifi MK, Astrakas LG, Poussaint TY, Plessis Ad A, Zurakowski D, Tzika AA. Prediction of adverse outcome with cerebral lactate level and apparent diffusion coefficient in infants with perinatal asphyxia. Radiology. 2002;225:859–70.
Miller SP, Newton N, Ferriero DM, et al. Predictors of 30-month outcome after perinatal depression: role of proton MRS and socioeconomics factors. Pediatr Res. 2002;52:71–7.
Loose JM, Miller SL, Supramanian VG, et al. Hypoxia induced activin secretion by the fetoplacental unit: differential responses related to gestation. BJOG. 2004;111:1346–52.
van Cappellen van Walsum AM, Heerschap A, Nijhuis JG, Oeseburg B, Jongsma HW. Proton magnetic resonance spectroscopy of fetal lamb brain during hypoxia. Am J Obstet Gynecol. 1998;179:756–7.
Dixon JC, Cady EB, Priest AN, Thornton JS, Peebles DM. Growth restriction and the cerebral metabolic response to acute hypoxia of chick embryos in-ovo: a proton magnetic resonance spectroscopy study. Brain Res Dev Brain Res. 2005;160:203–10.
Robinson JN, Cleary-Goldman J, Arias-Mendoza F, et al. Detection of fetal lactate with two-dimensional-localized proton magnetic resonance spectroscopy. Obstet Gynecol. 2004;104:1208–10.
Azpurua HB, Alvarado A, Mayobre F, Salom T, Copel JA, Guevara-Zuloaga F. Metabolic assessment of the brain using proton magnetic resonance spectroscopy in a growth-restricted human fetus: case report. Am J Perinatol. 2008;25:305–9.
Charles-Edwards GD, Jan W, To M, Maxwell D, Keevil SF, Robinson R. Non-invasive detection and quantification of human foetal brain lactate in utero by magnetic resonance spectroscopy. Prenat Diagn. 2010;30:260–6.
Leth H, Toft P, Pryds O, Peitersen B, Lou H, Henriksen O. Brain lactate in preterm and growth-retarded neonates. Acta Paediatr. 1995;82:495–9.
Cady E. Metabolite concentrations and relaxation in perinatal cerebral hypoxic-ischemic injury. Neurochem Res. 1996;21:1043–52.
Sanz-Cortes M, Figueras F, Bargallo N, Padilla N, Amat-Roldan I, Gratacos E. Abnormal brain microstructure and metabolism in small-for-gestational-age term fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol. 2010;36:159–65.
Robertson NJ, Lewis RH, Cowan FM, et al. Early increases in brain myo-inositol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy. Pediatr Res. 2001;50:692–700.
Kok RD, Steegers-Theunissen RPM, Eskes TKA, Heerschap A, van den Berg PP. Decreased relative brain tissue levels of inositol in fetal hydrocephalus. Am J Obstet Gynecol. 2003;188(4):978–80.
Bluml S, McComb JG, Ross BD. Differentiation between cortical atrophy and hydrocephalus using 1H MRS. Magn Reson Med. 1997;37:395–403.
Wolfberg A, Robinson JN, Mulkern R, Rybicki F, Du Plessis AJ. Identification of fetal cerebral lactate using magnetic resonance spectroscopy. Am J Obstet Gynecol. 2007;196:e-9–11.
Robinson JN, Norwitz ER, Mulkern R, Brown SA, Rybicki F, Tempany CMC. Prenatal diagnosis of pyruvate dehydrogenase deficiency using magnetic resonance imaging. Prenat Diagn. 2001;21:1053–6.
Brown RM, Dahl HHM, Brown GK. X-chromosome localization of the functional gene for the El α (alpha) subunit of the human pyruvate dehydrogenase complex. Genomics. 1989;41:74–81.
Brown GK, Otero LJ, Le Gris M, Brown RM. Pyruvate dehydrogenase deficiency. J Med Genet. 1994;31:875–9.
Cross JH, Connelly A, Gadian DG, et al. Clinical diversity of pyruvate dehydrogenase deficiency. Pediatr Neurol. 1994;10:276–83.
Shevell MI, Matthews PM, Scriver CR, et al. Cerebral dysgenesis lactic academia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency. Pediatr Neurol. 1994;11:224–9.
Hernandez MJ, Vannucci RC, Salcedo A, Brennan RW. Cerebral blood flow and metabolism during hypoglycemia in newborn dogs. J Neurochem. 1980;35:622–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Limperopoulos, C. (2013). Magnetic Resonance Spectroscopy of the Fetal Brain. In: Blüml, S., Panigrahy, A. (eds) MR Spectroscopy of Pediatric Brain Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5864-8_19
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5864-8_19
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5863-1
Online ISBN: 978-1-4419-5864-8
eBook Packages: MedicineMedicine (R0)